obesity drug news today glp-1 october 21 2025 Weight-Loss Drugs Ride Health, Wellness Wave Obesity GLP-1 Market Size to
Description
Why Supplementation Matters with GLP-1 When taking GLP-1 medications, its essential to consider the potential nutritional gaps that might arise
No intermediary steps
Recent studies have shown that patients on high-dose semaglutide can lose an average of 15% to 20% of their body weight, a level previously achievable only with bariatric surgery
And now, Novo Nordisk has taken a step that could signal semaglutide, the key ingredient in Ozempic and Wegovy, could soon come off the FDA shortage list, too
What TeleHealth Med states is included: provider consultations (both live and via electronic form submission), medication where clinically appropriate fulfilled through a compounding pharmacy, free overnight cold shipping, ongoing care support, and customer support access
In contrast, no correlation was shown between the two in a cohort study on the effect of GLP-1RAs on melanoma or non-melanoma skin cancers risk [49]
